Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.135 EUR | -4.26% | +5.69% | -57.04% |
May. 03 | Crossject: praised for extended agreement on Zepizure | CF |
May. 02 | Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-57.04% | 91.35M | |
-3.50% | 209M |
- Stock Market
- Equities
- ALCJ Stock
- News Crossject
- French Pharmaceutical Crossject Taps Syneos Health for US Commercialization of Epilepsy Rescue Treatment